Forte Biosciences (FBRX) Treasury Shares (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Treasury Shares data on file, last reported at $391437.0 in Q1 2026.

• On a quarterly basis, Treasury Shares rose 1159.17% year-over-year to $391437.0 in Q1 2026; TTM through Mar 2026 was $391437.0, a 1159.17% increase from a year earlier, with the FY2025 full-year figure at $47237.0, up 65.53% from the prior year.
• Treasury Shares for Q1 2026 stood at $391437.0, up from $47237.0 in the prior quarter.
• Over the last five years, Treasury Shares for FBRX reached as high as $1.3 million in Q1 2023 and fell as low as $24387.0 in Q3 2025.
• Historically, Treasury Shares has averaged $400179.7 across 5 years, with a median of $162201.0 in 2022.
• Across the five-year window, Treasury Shares jumped 1625.67% in 2022 and slumped 97.24% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $162201.0 in 2022, then plunged by 73.96% to $42237.0 in 2023, then sank by 32.44% to $28537.0 in 2024, then soared by 65.53% to $47237.0 in 2025, then surged by 728.67% to $391437.0 in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $391437.0 in Q1 2026, $47237.0 in Q4 2025, and $24387.0 in Q3 2025.